| Literature DB >> 29914197 |
Valentina Monistero1, Hans Ulrich Graber2, Claudia Pollera3, Paola Cremonesi4, Bianca Castiglioni5, Enriqueta Bottini6, Alejandro Ceballos-Marquez7, Laura Lasso-Rojas8, Volker Kroemker9, Nicole Wente10, Inge-Marie Petzer11, Carlos Santisteban12, Jeff Runyan13, Marcos Veiga Dos Santos14, Bruna Gomes Alves15, Renata Piccinini16, Valerio Bronzo17, Mohamed Salah Abbassi18, Meriam Ben Said19, Paolo Moroni20,21.
Abstract
Staphylococcus aureus is recognized worldwide as one of the major agents of dairy cow intra-mammary infections. This microorganism can express a wide spectrum of pathogenic factors used to attach, colonize, invade and infect the host. The present study evaluated 120 isolates from eight different countries that were genotyped by RS-PCR and investigated for 26 different virulence factors to increase the knowledge on the circulating genetic lineages among the cow population with mastitis. New genotypes were observed for South African strains while for all the other countries new variants of existing genotypes were detected. For each country, a specific genotypic pattern was found. Among the virulence factors, fmtB, cna, clfA and leucocidins genes were the most frequent. The sea and sei genes were present in seven out of eight countries; seh showed high frequency in South American countries (Brazil, Colombia, Argentina), while sel was harboured especially in one Mediterranean country (Tunisia). The etb, seb and see genes were not detected in any of the isolates, while only two isolates were MRSA (Germany and Italy) confirming the low diffusion of methicillin resistance microorganism among bovine mastitis isolates. This work demonstrated the wide variety of S. aureus genotypes found in dairy cattle worldwide. This condition suggests that considering the region of interest might help to formulate strategies for reducing the infection spreading.Entities:
Keywords: S. aureus; dairy cow; genotypes; mastitis; virulence genes
Mesh:
Substances:
Year: 2018 PMID: 29914197 PMCID: PMC6024761 DOI: 10.3390/toxins10060247
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Distribution of genotypes in the eight countries.
| Country | Genotypic Cluster (CL) | Genotype (Isolate No.) | New Genotypes or Variants | Total Strains |
|---|---|---|---|---|
| CLC | GTC (6, 15) | |||
| CLI | GTII (1, 4, 5, 7) | |||
| GTIII (10, 11, 14) | ||||
| GTIV (9) | ||||
| Argentina | GTIVI (12) | GTIV, GTIVI | 16 | |
| CLP | GTP (8) | |||
| CLR | GTRI (2, 3, 16) | |||
| GTRVI (13) | ||||
| CLAQ | GTAQ (31) | |||
| GTAQI (30) | ||||
| CLBA | GTBA (17) | |||
| CLBN | GTBN (29) | |||
| GTBNI (20) | ||||
| GTBNII (23) | ||||
| Brasil | CLBY | GTBY (18, 19, 21, 28) | GTBNI, GTBNII, GTBYI, GTAQI | 15 |
| GTBYI (24, 25) | ||||
| CLC | GTCIII (26) | |||
| CLS | GTSI (22) | |||
| CLZ | GTZ (27) | |||
| CLA | GTAI (33) | |||
| CLAO | GTAO (39, 40, 41) | |||
| GTAOI (38, 43, 44, 46) | ||||
| Colombia | GTAOII (32, 42) | GTAOI, GTAOII | 15 | |
| CLBY | GTBY (45) | |||
| CLI | GTII (35, 36, 37) | |||
| CLR | GTR (34) | |||
| CLC | GTCI (54, 55, 56, 57, 59) | |||
| CLR | GTR (47, 48, 49, 51) | |||
| Germany | GTRI (58, 60, 61, 63) | 17 | ||
| GTRII (50, 62) | ||||
| GTRVI (52) | ||||
| CLS | GTS (53) | |||
| CLB | GTB (64, 65, 66, 78, 80) | |||
| CLBG | GTBG (70) | |||
| CLBQ | GTBQI (73, 79) | |||
| CLC | GTCI (69, 75) | |||
| Italy | GTCII (76) | GTRXIII | 17 | |
| CLR | GTRI (67, 68) | |||
| GTRXIII (72) | ||||
| GTRVI (71) | ||||
| CLS | GTS (77) | |||
| CLZ | GTZ (74) | |||
| CLAI | GTAI (93) | |||
| CLC | GTC (82, 83, 85, 86, 88, 94, 96) | |||
| GTCI (81, 87, 91) | ||||
| New York State | GTCIII (90) | GTCV, GTIV | 17 | |
| GTCV (95) | ||||
| CLI | GTII (89) | |||
| GTIV (92, 97) | ||||
| CLR | GTRI (84) | |||
| CLAR | GTAR (101) | |||
| CLBH | GTBH (98) | |||
| South Africa | CLBZ | GTBZ (99, 100, 105) | GTAR, GTBZ, GTCA | 11 |
| CLCA | GTCA (103) | |||
| CLR | GTR (102, 104, 107, 108) | |||
| GTRVI (106) | ||||
| CLAJ | GTAJ (111) | |||
| CLBW | GTBWII (110) | |||
| Tunisia | CLCA | GTCA (113, 114) | GTCA | 12 |
| CLCB | GTCB (119) | |||
| CLR | GTRI (109) | |||
| GTRVI (112, 115, 116, 117, 118, 120) |
Figure 1Representation of the major genotypes with their variants combined into genotypic clusters (CL).
Molecular characteristics of strains isolated in Argentina.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GTII | + | + | + | + | - | + | + | - | - | - | - | + | - | |
| 2 | GTRI | + | + | + | + | + | + | + | - | - | + | - | - | - | |
| 3 | GTRI | + | - | + | + | + | + | + | - | - | - | - | - | - | |
| 4 | GTII | - | - | + | + | + | + | + | - | - | - | - | - | - | |
| 5 | GTII | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 6 | GTC | + | + | + | + | + | + | - | - | - | + | - | + | - | |
| 7 | GTII | + | + | + | + | + | + | - | - | - | + | - | + | - | |
| 8 | GTP | + | + | + | - | + | + | + | - | - | + | - | - | - | |
| 9 | GTIV * | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 10 | GTIII | + | + | - | + | + | + | + | - | - | + | - | - | - | |
| 11 | GTIII | + | + | - | + | - | + | + | - | - | - | - | - | - | |
| 12 | GTIVI * | + | + | + | + | + | + | + | - | - | - | - | + | - | |
| 13 | GTRVI * | + | + | - | + | + | + | + | - | - | - | - | - | - | |
| 14 | GTIII | + | + | + | + | - | + | + | - | - | - | - | - | - | |
| 15 | GTC | + | + | + | + | + | + | + | - | - | - | - | + | - | |
| 16 | GTRI | + | + | + | + | + | + | - | - | - | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in Brazil.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | GTBA | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 18 | GTBY | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 19 | GTBY | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 20 | GTBNI * | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 21 | GTBY | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 22 | GTSI | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 23 | GTBNII | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 24 | GTBYI | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 25 | GTBYI | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 26 | GTCIII | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 27 | GTZ | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 28 | GTBY | + | + | + | + | + | + | + | - | - | - | - | - | - | - |
| 29 | GTBN | + | + | + | + | + | + | + | - | - | - | - | - | - | - |
| 30 | GTAQI | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 31 | GTAQ | + | + | + | + | + | + | + | - | - | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in Colombia.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32 | GTAOII * | - | + | + | + | - | + | + | - | - | - | - | - | - | - |
| 33 | GTAI | + | + | + | + | + | + | + | + | - | + | - | - | - | |
| 34 | GTR | + | + | + | + | + | + | + | + | - | + | - | - | - | |
| 35 | GTII | + | + | + | + | + | + | + | + | - | + | - | - | - | |
| 36 | GTII | + | + | + | + | - | + | - | + | - | + | - | - | - | |
| 37 | GTII | + | + | + | + | + | + | - | + | - | + | - | - | - | |
| 38 | GTAOI * | + | + | + | + | + | + | + | + | - | + | - | - | - | |
| 39 | GTAO | + | + | + | + | + | + | + | - | - | + | - | - | - | |
| 40 | GTAO | + | + | + | + | + | + | + | - | - | + | - | - | - | |
| 41 | GTAO | + | - | + | + | - | + | + | + | - | + | - | - | - | |
| 42 | GTAOII * | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 43 | GTAOI * | + | + | + | + | + | + | + | - | - | + | - | - | - | |
| 44 | GTAOI * | + | + | + | + | + | + | + | - | - | - | - | - | - | |
| 45 | GTBY | + | + | + | - | - | + | + | - | - | - | - | - | - | |
| 46 | GTAOI * | + | + | + | + | + | + | + | - | - | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in Germany.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47 | GTR | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 48 | GTR | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 49 | GTR | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 50 | GTRII | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 51 | GTR | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 52 | GTRVI | + | + | + | + | - | + | - | - | - | - | - | - | - | - |
| 53 | GTS | - | + | + | + | - | - | - | - | - | - | - | - | - | + |
| 54 | GTCI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 55 | GTCI | + | - | + | + | + | + | - | - | - | - | - | + | - | |
| 56 | GTCI | + | - | + | + | + | + | - | - | - | - | - | + | - | |
| 57 | GTCI | + | - | + | + | + | + | - | - | - | - | - | + | - | |
| 58 | GTRI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 59 | GTCI | + | - | + | + | + | + | - | - | - | - | - | + | - | |
| 60 | GTRI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 61 | GTRI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 62 | GTRII | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 63 | GTRI | + | + | + | + | + | + | - | - | - | - | - | - | - |
Molecular characteristics of strains isolated in Italy.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | GTB | + | + | + | + | - | + | - | - | - | - | - | - | - | - |
| 65 | GTB | + | + | + | + | - | + | - | - | - | - | - | - | - | |
| 66 | GTB | - | + | + | + | - | + | - | - | - | - | - | - | - | |
| 67 | GTRI | + | + | + | + | - | + | - | - | - | - | - | - | - | - |
| 68 | GTRI | + | + | + | + | - | + | - | - | - | - | - | - | - | - |
| 69 | GTCI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 70 | GTBG | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 71 | GTRVI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 72 | GTRXIII * | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 73 | GTBQI | + | + | + | + | - | + | - | - | - | - | - | - | - | |
| 74 | GTZ | + | + | + | + | - | + | - | - | - | - | - | - | - | |
| 75 | GTCI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 76 | GTCII | + | + | + | + | + | + | - | - | - | - | - | + | - | |
| 77 | GTS | - | + | + | + | + | + | - | - | - | - | - | - | + | |
| 78 | GTB | + | + | + | + | + | + | - | + | - | + | - | - | - | |
| 79 | GTBQI | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 80 | GTB | - | + | + | + | - | + | - | - | - | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in New York State.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81 | GTCI | + | - | + | + | - | + | - | - | - | - | - | - | - | |
| 82 | GTC | - | - | + | + | + | + | - | - | - | - | - | - | - | |
| 83 | GTC | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 84 | GTRI | + | + | + | + | - | + | - | - | - | - | - | - | - | |
| 85 | GTC | + | - | + | + | + | + | - | - | - | - | - | - | - | |
| 86 | GTC | + | - | + | + | + | + | - | - | - | - | - | - | - | |
| 87 | GTCI | + | - | + | + | + | + | - | - | - | - | - | - | - | |
| 88 | GTC | + | - | + | + | + | + | - | - | - | - | - | - | - | |
| 89 | GTII | + | + | + | + | + | + | - | - | - | - | - | - | - | |
| 90 | GTCIII | - | - | - | - | + | + | - | - | - | - | - | - | - | |
| 91 | GTCI | - | - | + | + | + | + | - | - | - | - | - | - | - | |
| 92 | GTIV * | - | + | + | + | + | + | - | - | - | - | - | - | - | |
| 93 | GTAI | + | - | + | - | - | + | - | - | - | - | - | - | - | |
| 94 | GTC | - | - | + | + | + | + | - | - | - | - | - | - | - | |
| 95 | GTCV * | - | - | - | + | + | + | + | - | - | - | - | - | - | |
| 96 | GTC | - | + | + | + | + | + | - | - | - | - | - | - | - | |
| 97 | GTIV * | - | + | + | + | - | + | + | - | - | - | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in South Africa.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98 | GTBH | + | + | + | + | - | + | + | - | - | + | - | - | - | |
| 99 | GTBZ * | - | + | + | + | - | + | - | - | - | + | - | - | - | |
| 100 | GTBZ * | - | + | + | + | - | + | - | - | - | + | - | - | - | |
| 101 | GTAR * | - | + | + | + | - | + | - | - | - | + | - | - | - | |
| 102 | GTR | + | + | + | + | + | + | - | - | - | + | - | - | - | |
| 103 | GTCA * | + | + | + | + | - | + | - | + | - | + | + | - | - | |
| 104 | GTR | + | + | + | + | - | + | - | - | - | + | - | - | - | |
| 105 | GTBZ * | - | - | + | + | - | + | - | - | - | + | - | - | - | |
| 106 | GTRVI | + | + | + | + | + | + | - | - | - | + | - | - | - | |
| 107 | GTR | + | + | + | + | - | + | + | - | - | + | - | - | - | |
| 108 | GTR | + | + | + | + | - | + | + | - | - | + | - | - | - | - |
* new genotypes or new variants.
Molecular characteristics of strains isolated in Tunisia.
| Isolates | RS-PCR | Enterotoxins Positive | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109 | GTRI | + | + | + | - | - | + | - | - | - | - | - | - | - | - |
| 110 | GTBWII | + | + | + | + | + | + | - | - | - | - | - | + | - | |
| 111 | GTAJ | + | + | + | + | + | + | - | - | - | - | - | + | - | |
| 112 | GTRVI | + | + | + | + | + | + | - | + | + | + | - | - | - | - |
| 113 | GTCA | + | + | + | + | + | + | - | - | + | - | - | - | - | |
| 114 | GTCA | + | + | + | + | + | + | - | + | - | + | - | - | - | |
| 115 | GTRVI | + | + | + | + | + | + | - | - | - | - | - | - | - | - |
| 116 | GTRVI | + | + | + | + | + | + | - | - | + | - | - | - | - | - |
| 117 | GTRVI | + | + | + | + | + | + | - | - | - | - | - | - | - | - |
| 118 | GTRVI | + | + | + | + | + | + | - | - | - | - | - | - | - | - |
| 119 | GTCB | + | + | + | + | + | + | - | + | + | - | - | - | - | - |
| 120 | GTRVI | + | + | + | + | + | - | - | + | + | + | - | - | - | - |
World survey on S. aureus cow isolates: participating countries, total isolates analyzed per country, number of isolated from clinical mastitis or high somatic cell count (H) samples, and type of sample collection (C = composite milk sample; Q = quarter milk sample).
| Country | Total Isolates Analyzed per Country | |||
|---|---|---|---|---|
| Clinical Mastitis | High SCC (H) | Number of Farms | Type of Sample | |
| 16 | 10 | C | ||
| 15 | 12 | Q | ||
| 15 | 11 | Q | ||
| 17 | 17 | Q | ||
| 17 | 15 | Q | ||
| 17 | 13 | Q | ||
| 11 | 9 | Q | ||
| 12 | 10 | C | ||
| 93 | 27 | 97 | ||
Primer used in this study for S. aureus isolates characterization.
| Target Gene | Primer Sequence (5′-3′) | Amplification Size | Reference |
|---|---|---|---|
| Invasion | |||
| GGCTTCAGTGCTTGTAGG | 1000 bp | [ | |
| TTTTCAGGGTCAATATAAGC | |||
| CCGCTTCAACTTCAGCCTAC | 204 bp | [ | |
| TTAGGTGCTACAGGGGCAAT | |||
| AGTTCAGCAAATGCATCACA | 400 bp | [ | |
| TAGCCAAGCCTTGACGAACT | |||
| AATGTTAGCTGCAACTTTGTCA | 831 bp | [ | |
| CTTTCTGCGTAAATACCAGTTCTA | |||
| TGGATGTTACCTATGCAACCTAC | 780 bp | [ | |
| GTTCGTTTCCATATAATGAATCACTAC | |||
| TGAAAAAGGTTCAAAGTTGATACGAG | 269 bp | [ | |
| TGTATTCGATAGCAAAAGCAGTGCA | |||
| ATCATTAGGTAAAATGTCTGGACATGATCA | 433 bp | [ | |
| GCATCAAGTGTATTGGATAGCAAAAGC | |||
| ATACTTGCGGGAACTTTAGCAA | 320 bp | [ | |
| TTTTAGTGCTTCGTCAATTTCG | |||
| TTTTTAACGGCAGGAATCAGTA | 404 bp | [ | |
| TGCATATTCATTAGTTTTTCCAGG | |||
| AATGAAGATGCGAATCATGTTG | 725 bp | [ | |
| CATCCATTTTTGTTTGCGTAGA | |||
| TGAGGTAAGTGCATCAAGTTCA | 403 bp | [ | |
| CCTTTGTAATTAAGTTGAATCCAGG | |||
| AAAGCGTTGCCTAGTGGAGA | 192 bp | [ | |
| AGTGCCTTCCCAAACCTTTT | |||
| Interfere with host defense mechanism | |||
| ATGGCAGCATCAGCTTGATA | 300 bp | [ | |
| TTTCCAATAACCACCCGTTT | |||
| CTAGTGCATTTGTTATTCAA | 120 bp | [ | |
| TGCATTGACACCATAGTACT | |||
| ACGGCTATATACATTCAATT | 200 bp | [ | |
| TCCATCGATAATATACCTAA | |||
| TAAGGAGGTGGTGCCTATGG | 180 bp | [ | |
| CATCGAAACCAGCCAAAGTT | |||
| TCGCATCAAACTGACAAACG | 478 bp | [ | |
| GCAGGTACTCTATAAGTGCC | |||
| ACCAGACCCTATGCCAGATG | 371 bp | [ | |
| TCCCATTATCAAAGTGGTTTCC | |||
| TCAATTCAAAAGAAATGGCTCA | 339 bp | [ | |
| TTTTTCCGCGCTGTATTTTT | |||
| TACCAATTAACTTGTGGATAGAC | 170 bp | [ | |
| CTCTTTGCACCTTACCGC | |||
| CCACCTGTTGAAGGAAGAGG | 432 bp | [ | |
| TGCAGAACCATCAAACTCGT | |||
| TCACATCATATGCGAAAGCAG | 463 bp | [ | |
| TCGGACAATATTTTTCTGATCTTT | |||
| CTCAAGGTGATATTGGTGTAGG | 529 bp | [ | |
| CAGGCAGTCCATCTCCTGTA | |||
| GGTTTTCAATGTTCTGGTGGT | 306 bp | [ | |
| AACCAACGGTTCTTTTGAGG | |||
| CACCAGAATCACACCGCTTA | 240 bp | [ | |
| CTGTTTGATGCTTGCCATTG | |||
| Antibiotic resistance | |||
| GTAGAAATGACTGAACGTCCGATAA | 310 bp | [ | |
| CCAATTCCACATTGTTTCGGTCTAA |